ABVC Biopharma Inc (ABVC) — Long-term Investment Intensity
ABVC Biopharma Inc (ABVC) has a Long-term Investment Intensity of 9.4% as of March 2026. Long-term investments of $1.85 Million represent 9.4% of total assets of $19.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ABVC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ABVC Biopharma Inc Long-term Investment Intensity (2017–2025)
This chart shows how ABVC Biopharma Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2025. As of March 2026, the intensity stands at 9.4%, reflecting long-term investments of $1.85 Million against total assets of $19.73 Million USD. Explore ABVC Biopharma Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for ABVC Biopharma Inc (2017–2025)
The table below presents the year-by-year Long-term Investment Intensity for ABVC Biopharma Inc from 2017 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is ABVC Biopharma Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 8.9% | $1.88 Million | $21.06 Million | ▼ -21.0 pp |
| 2024 | 30.0% | $2.26 Million | $7.54 Million | ▼ -2.5 pp |
| 2023 | 32.5% | $2.53 Million | $7.78 Million | ▲ +24.8 pp |
| 2022 | 7.7% | $842.07K | $10.93 Million | ▲ +0.9 pp |
| 2021 | 6.8% | $932.75K | $13.70 Million | ▼ -1.3 pp |
| 2020 | 8.1% | $1.19 Million | $14.77 Million | ▼ -40.5 pp |
| 2019 | 48.6% | $3.36 Million | $6.93 Million | ▼ -14.8 pp |
| 2017 | 63.4% | $4.19 Million | $6.60 Million | — |